CANNTAB THERAPEUTICS LTD has a total of 20 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are Bow River LLC, DONG XINFANG and GUFIC BIOSCIENCES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Renwick Jeff | 16 |
#2 | Lefler Robert Scott | 12 |
#3 | Laxminaraya Joshi | 5 |
#4 | Lefler Robert | 4 |
#5 | Renwick Jeff Scott | 4 |
Publication | Filing date | Title |
---|---|---|
CA3005885A1 | Sustained release cannabinoid pellets | |
CA3005889A1 | Sustained release cannabinoid formulations | |
US2018263954A1 | Sustained Release Cannabinoid Formulations | |
US2018263953A1 | Sustained Release Cannabinoid Formulations | |
WO2018165740A1 | Modified release multi-layer tablet cannabinoid formulations | |
US2018250262A1 | Sustained release cannabinoid formulations | |
AU2018216173A1 | Flash-melt cannabinoid formulations | |
CA3050150A1 | Immediate release cannabidiol formulations | |
AU2017334283A1 | Sustained release cannabinoid formulations |